Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised with the ‘Most Innovative CDMO (Cell & Gene Therapy)’ award at the CDMO ...

A Japanese research team pushed mouse cloning to its breaking point, producing 1,206 clones from a single donor line before ...

Exl-111 is a trifunctional ECRI designed to disarm allergic effector cells at the source of activation by targeting the IgE axis. Exl-111 is currently being evaluated in the Phase 1 DISARM trial, a ...

Cloud-Clone drives technological innovation for obesity research, providing validated targets for precise matching of ...

A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...

It could be more difficult to have a baby in space because sperm could get lost, a new study has warned. Research suggests that sperm’s navigation may be confused by the lack of gravity and therefore ...

Scientists have developed a new class of microscopic antibody fragments capable of functioning inside human cells, overcoming a long-standing limitation in biomedical science.

UC Riverside researchers have identified a mechanism that allows plants to rapidly slow growth in response to extreme ...

Timely resolution of inflammation induced by standard-of-care cancer treatments can be a common approach to prevent ...

A new study found that microgravity simulated on Earth hindered sperm cell movement, egg fertilization and embryo development ...

Once considered cellular junk, non-coding RNAs are emerging as key players in everything from brain development to cancer — ...